Dr. Manoela Mota, MD

Dr. Mota practices at Tallahassee Endoscopy Center in Tallahassee, Florida.

Dr. Mota's NPI, 1548689060, was assigned on April 11, 2014. Dr. Mota graduated from Brody School Of Medicine At East Carolina University in 2010. Dr. Mota holds Florida license ME143846.

Dr. Mota's primary practice is Tallahassee Endoscopy Center, at 2400 Miccosukee Rd, Tallahassee, FL 32308. The practice phone is (904) 942-4706.

Dr. Mota's primary practice is Tallahassee Endoscopy Center in Tallahassee, Florida. Dr. Mota is also affiliated with Tallahassee Memorial Hospital. The medical group on file is Digestive Disease Clinic. Dmand AI also links Dr. Mota to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mota practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mota's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mota is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mota's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Mota treats.

CMS data shows 560 Medicare services from Dr. Mota across 12 procedure codes in 2024, for 243 Medicare patients. Medicare paid $50,977 for them.

CMS counts 243 Medicare patients who saw Dr. Mota in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mota's median patient age at 55, with 68% women.

In 2024, Dr. Mota wrote 1,252 Medicare Part D claims for 421 patients. 83% of them were for generic drugs. CMS names the drug for 1,046 of them, across 21 drugs with 11 or more claims each, at $306,327 in total drug cost. In 2023, CMS named 1,089 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mota for performance year 2024, reported as part of a group. Dr. Mota accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 113 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mota, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Mota, published from 2016 to 2020. Dr. Mota's most frequent co-authors are Andreas Giovanni Zori, MD, Roniel Cabrera, MD and Michael Martin Feely, DO.

CMS Open Payments shows 218 general payments to Dr. Mota from 27 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,990.

Dr. Mota graduated from Brody School Of Medicine At East Carolina University in 2010.

Dr. Mota is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.